A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
Clinical trial NCT06776770 · RECRUITING
Trial details
- NCT number
- NCT06776770
- Sponsor
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-03
- Primary completion
- 2026-09-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.